News
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...
British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...
Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.
InsideNoVa on MSN9d
AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobsIn a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...
For many rare disease patients and their families, this often results in years of uncertainty, misdiagnosis, and limited or ...
AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
Seasoned communications leader Rikki Jones joins biopharmaceutical giant AstraZeneca as Head of Communications, International ...
The study’s findings could significantly impact AstraZeneca’s market position by potentially enhancing its reputation in heart failure treatment, influencing stock performance positively. As the ...
A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback